Outcomes and diagnostic challenges posed by incidental cholangiocarcinoma after liver transplantation

Transplantation

Volumn 91, Issue 12, 2011, Pages 1392-1397

  Ali, Jason M ^a   Bonomo, Luca ^a   Brais, Rebecca ^a   Griffiths, William J H ^a   Lomas, David J ^a   Huguet, Emmanuel L ^a   Praseedom, Raaj K ^a   Jamieson, Neville V ^a   Jah, Asif ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Incidental cholangiocarcinoma; Liver transplantation; Primary sclerosing cholangitis; Transplantation assessment

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FATALITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INCIDENCE; INCIDENTAL FINDING; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; OVERALL SURVIVAL; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; TUMOR RECURRENCE;

ADULT; AGED; CHOLANGIOCARCINOMA; FEMALE; HUMANS; INCIDENTAL FINDINGS; LIVER FAILURE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79958765960     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821aba57     Document Type: Article

References (37)

1. Yeo CJ, Pitt HA, Cameron JL. Cholangiocarcinoma. Surg Clin North Am 1990; 70: 1429.
2. Gatto M, Bragazzi MC, Semeraro R, et al. Cholangiocarcinoma: Update and future perspectives. Dig Liver Dis 2010; 42: 253.
3. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB 2008; 10: 77.
4. Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: A true increase? J Hepatol 2004; 40: 472.
5. Malhi H, Gores GJ. Cholangiocarcinoma: Modern advances in understanding a deadly old disease. J Hepatol 2006; 45: 856.
6. Abbas G, Lindor KD. Cholangiocarcinoma in primary sclerosing cholangitis. J Gastrointest Cancer 2009; 40: 19.
7. Abu-Elmagd KM, Selby R, Iwatsuki S, et al. Cholangiocarcinoma and sclerosing cholangitis: Clinical characteristics and effect on survival after liver transplantation. Transplant Proc 1993; 25: 1124.
8. Pascher A, Jonas S, Neuhaus P. Intrahepatic cholangiocarcinoma: Indication for transplantation. J Hepatobiliary Pancreat Surg 2003; 10: 282.
9. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: Results in 207 patients. Transplantation 2000; 69: 1633.
10. Becker NS, Rodriguez JA, Barshes NR, et al. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18 year period. J Gastrointest Surg 2008; 12: 117.
11. Heimbach JK, Gores GJ, Nagorney DM, et al. Liver transplantation for perihilar cholangiocarcinoma after aggressive neoadjuvent therapy: A new paradigm for liver and biliary malignancies? Surgery 2006; 140: 331.
12. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis: A 12 year single centre experience. Ann Surg 1997; 225: 472.
13. Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: Analysis of the Canadian experience. Liver Transpl 2005; 11: 1412.
14. Mazzafero V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
15. Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: The role of resection and orthotopic liver transplantation. Transplant Proc 2009; 41: 4023.
16. Robles R, Figueras J, Turrion VS, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg 2004; 239: 265.
17. Brandsæter B, Isoniemi H, Broomé U, et al. Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 2004; 40: 815.
18. Morris-Stiff G, Bhati C, Olliff S, et al. Cholangiocarcinoma complicating primary sclerosing cholangitis: A 24 year experience. Dig Surg 2008; 25: 126.
19. Schwartz JJ, Hutson WR, Gayowski TJ, et al. Liver transplantation for cholangiocarcinoma. Transplantation 2009; 88: 295.
20. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010; 51:2: 660.
21. Maggs JR, Chapman RW. An update on primary sclerosing cholangitis. Curr Opin Gastroenterol 2008; 24: 377.
22. Charatcharoenwitthaya P, Enders FB, Halling KC, et al. Utility of serum tumour markers, imaging and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis. Hepatology 2008; 48: 1106.
23. Rimola J, Forner A, Reig M, et al. Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50: 791.
24. Kluge R, Schmidt F, Caca K, et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001; 33: 1029.
25. Lee SW, Kim HJ, Park JH, et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 2010; 45: 560.
26. Eloubeidi MA, Chen VK, Jhala NC, et al. Endoscopic-ultrasound guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2001; 2: 209.
27. Weber A, Schmid RM, Prinz C. Diagnostic approaches for cholangiocarcinoma. World J Gastroenterol 2008; 14: 4131.
28. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421.
29. Jarnagin WR. Management of small hepatocellular carcinoma: A review of transplantation, resection and ablation. Ann Surg Oncol 2010; 17: 1226.
30. Libbrecht L, Bielen D, Verslype C, et al. Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002; 8: 749.
31. Colli A, Fraquelli M, Casazza G. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: A systematic review. Am J Gastroenterol 2006; 101: 513.
32. Hayashi PH, Trotter JF, Forman L, et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadaveric allocation in the era of MELD. Liver Transpl 2004; 10: 42.
33. Silva MA, Hegab B, Hyde C, et al. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: A systematic review and meta-analysis. Gut 2008; 57: 1592.
34. Liver transplant candidates with hepatocellular carcinoma. United Network for Organ Sharing(UNOS)Policies 3.6.4.4. Available at: http://www. unos.org/PoliciesandBylaws2/policies/pdfs/policy-8.pdf. Accessed November 23, 2010.
35. Ahn SS, Kim MJ, Lim JS, et al. Added value of gadoxetic acid-enhanced hepatobiliary phaseMRimaging in the diagnosis of hepatocellular carcinoma. Radiology 2010; 255: 459.
36. Chen LD, Xu HX, Xie XY, et al. Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: Differential diagnosis with contrast enhanced ultrasound. Eur J Radiol 2010; 20: 743.
37. Edge SB, Byrd DB, Compton CC, et al. AJCC cancer staging manual [ed. 7]. New York: Springer; 2009.